mebeverine and Fatty Liver, Nonalcoholic

mebeverine has been researched along with Fatty Liver, Nonalcoholic in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Albadr, NA; Almasri, SA; Aloud, AA; Alshammari, GM; Alwadani, AH; Yahya, MA	1
Hirai, H; Kitamura, S; Matsumoto, K; Nakaya, M; Shojo, A	1

Other Studies

2 other study(ies) available for mebeverine and Fatty Liver, Nonalcoholic

Article	Year
The Synergistic Protective Effect of γ-Oryzanol (OZ) and N-Acetylcysteine (NAC) against Experimentally Induced NAFLD in Rats Entails Hypoglycemic, Antioxidant, and PPARα Stimulatory Effects. Nutrients, 2022, Dec-26, Volume: 15, Issue:1 Topics: Acetylcysteine; Animals; Antioxidants; Diet, High-Fat; Glucose; Hypoglycemic Agents; Liver; Male; Non-alcoholic Fatty Liver Disease; PPAR alpha; Rats	2022
Hypolipidemic effects of starch and γ-oryzanol from wx/ae double-mutant rice on BALB/c.KOR-Apoe(shl) mice. Bioscience, biotechnology, and biochemistry, 2013, Volume: 77, Issue:7 Topics: Animals; Apolipoproteins E; Body Weight; Cecum; Diet, High-Fat; Dietary Carbohydrates; Drug Interactions; Eating; Fatty Liver; Feces; Food, Genetically Modified; Gene Expression Regulation; Hypolipidemic Agents; Liver; Male; Mice; Mice, Inbred BALB C; Mutation; Non-alcoholic Fatty Liver Disease; Oryza; Phenylpropionates; Starch; Sucrose	2013

Article

Year

The Synergistic Protective Effect of γ-Oryzanol (OZ) and N-Acetylcysteine (NAC) against Experimentally Induced NAFLD in Rats Entails Hypoglycemic, Antioxidant, and PPARα Stimulatory Effects.

Nutrients, 2022, Dec-26, Volume: 15, Issue:1

Topics: Acetylcysteine; Animals; Antioxidants; Diet, High-Fat; Glucose; Hypoglycemic Agents; Liver; Male; Non-alcoholic Fatty Liver Disease; PPAR alpha; Rats

2022

Hypolipidemic effects of starch and γ-oryzanol from wx/ae double-mutant rice on BALB/c.KOR-Apoe(shl) mice.

Bioscience, biotechnology, and biochemistry, 2013, Volume: 77, Issue:7

Topics: Animals; Apolipoproteins E; Body Weight; Cecum; Diet, High-Fat; Dietary Carbohydrates; Drug Interactions; Eating; Fatty Liver; Feces; Food, Genetically Modified; Gene Expression Regulation; Hypolipidemic Agents; Liver; Male; Mice; Mice, Inbred BALB C; Mutation; Non-alcoholic Fatty Liver Disease; Oryza; Phenylpropionates; Starch; Sucrose

2013